OneCell Diagnostics is now 1Cell.Ai

Artificial Intelligence Redefining Patient’s Eligibility for Immunotherapy

Watch Now: Dr. Gowhar Shafi at Indian Cancer Congress 2023

Artificial Intelligence Redefining Patient Eligibility for Immunotherapy

Hear from Dr. Gowhar Shafi as he presents at the 3rd Indian Cancer Congress 2023, exploring how AI is transforming patient selection for immunotherapy. In this talk, Dr. Shafi discusses how advanced AI-driven analysis is enabling more precise, personalized eligibility assessments—ensuring the right patients receive the right treatments at the right time.
1Cell.Ai
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.